Results 211 to 220 of about 279,445 (313)

Circular RNA circSmad4 controls pulmonary fibrosis. [PDF]

Korean J Physiol Pharmacol
Jeong A, Kook T, Lee YG, Lim Y, Han A, Kim YK, Jeong D, Park WJ, Kwon DH, Kook H.   +9 more
europepmc   +1 more source

Expert Perspectives: Defining and managing progressive pulmonary fibrosis in systemic sclerosis

Arthritis &Rheumatology, Accepted Article.
‐‐
Devis Benfaremo, Dinesh Khanna, Corrado Campochiaro, Vincent Cottin, Fabrizio Luppi, Marco Matucci‐Cerinic, Gianluca Moroncini, Yannick Allanore   +7 more
wiley   +1 more source

The intersection of liver cirrhosis and pulmonary fibrosis. [PDF]

J Transl Med
Bayraktar EA, Salvatore M.
europepmc   +1 more source

Human Fibroblast‐Myeloid cell tissue atlas across lung, synovium, skin and heart

Arthritis &Rheumatology, Accepted Article.
Background The availability of single‐cell RNA sequencing (scRNAseq data) in different tissues and disease states provides an opportunity to compare cellular subsets and identify common and unique cellular activation. In this study, we aimed to characterize shared and tissue‐specific myeloid and stromal phenotypes and to uncover key cellular subtypes ...
Lucy MacDonald, Katerina Apostolopoulou, Olympia Hardy, Melpomeni Toitou, Gabriela Kania, Przemyslaw Blyszczuk, Raphael Micheroli, Thomas D Otto, Mariola Kurowska‐Stolarska, Caroline Ospelt   +9 more
wiley   +1 more source

Pulmonary Fibrosis Beyond the Lung: Adipose Tissue as a Systemic Modifier of Fibrotic Remodeling. [PDF]

Diagnostics (Basel)
Tsiri P, Crestani B, Mailleux A, Tzouvelekis A.   +3 more
europepmc   +1 more source

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

British Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki, Kiplin A. Patanwala, Jan‐Willem C. Alffenaar, Asad E. Patanwala   +3 more
wiley   +1 more source

Adverse side-effects of antifibrotic drugs in idiopathic pulmonary fibrosis-clarification of several points. [PDF]

J Thorac Dis
Jovanovic D, Mogulkoc N, Sterclova M, Kramer M, Müller V, Bartos V, Plackova M, Doubkova M, Lewandowska K, Szymanowska-Narloch A, Zurkova M, Ovesna P, Vasakova MK.   +12 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Decoding macrophage heterogeneity in the pulmonary fibrosis lung cancer transition. [PDF]

Front Immunol
Yu H, Zhao M, Li Q, Zhang Y.
europepmc   +1 more source